NewEdge Advisors, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.

Quarter-by-quarter ownership
NewEdge Advisors, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$4,647
-92.8%
1,480
-88.1%
0.00%
-100.0%
Q2 2023$64,397
+725.6%
12,480
+743.2%
0.00%
Q1 2023$7,800
+26796.6%
1,480
-85.9%
0.00%
Q4 2022$29
-99.9%
10,4800.0%0.00%
-100.0%
Q3 2022$43,000
-6.5%
10,480
-8.7%
0.00%0.0%
Q2 2022$46,000
-19.3%
11,4800.0%0.00%0.0%
Q1 2022$57,000
-39.4%
11,480
-14.8%
0.00%0.0%
Q4 2021$94,000
-30.4%
13,4800.0%0.00%
-66.7%
Q3 2021$135,000
-30.8%
13,480
-2.2%
0.00%
-40.0%
Q2 2021$195,000
-13.7%
13,7800.0%0.01%
-28.6%
Q1 2021$226,000
-42.9%
13,780
-28.1%
0.01%
-46.2%
Q4 2020$396,000
+137.1%
19,153
-12.9%
0.01%
+116.7%
Q3 2020$167,000
-16.5%
21,980
-8.3%
0.01%
-25.0%
Q2 2020$200,000
+65.3%
23,980
-2.0%
0.01%
+33.3%
Q1 2020$121,000
+18.6%
24,480
-5.8%
0.01%
+50.0%
Q4 2019$102,000
-17.7%
25,980
-8.0%
0.00%
-50.0%
Q2 2019$124,000
-13.9%
28,250
-22.1%
0.01%
-11.1%
Q1 2019$144,0000.0%36,2500.0%0.01%0.0%
Q4 2018$144,000
-49.3%
36,250
-12.1%
0.01%
-59.1%
Q3 2018$284,000
+4.8%
41,2500.0%0.02%
-12.0%
Q2 2018$271,000
+1.9%
41,2500.0%0.02%
-16.7%
Q1 2018$266,000
+33.0%
41,2500.0%0.03%
+11.1%
Q4 2017$200,000
-25.4%
41,250
-6.8%
0.03%
-35.7%
Q3 2017$268,000
-99.9%
44,250
-6.3%
0.04%
-20.8%
Q2 2017$306,653,000
+80386.4%
47,2500.0%0.05%
-39.1%
Q1 2017$381,00047,2500.09%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders